NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology.
NeuroSigma's Monarch eTNS® System is a bioelectronic medical device that uses external trigeminal nerve stimulation to treat neurological and neuropsychiatric disorders. In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD.
The new Monarch Pediatric Care Co-Pay Program is making eTNS therapy available to a substantially greater number of children diagnosed with ADHD.
Company Details
- Employees
- 9
- Address
- 10960 Wilshire Blvd, Los Angeles,california 90024,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.neurosigma.com/
- Keywords
- San Diego.
- HQ
- Los Angeles, California
Neurosigma Questions
Neurosigma's website is https://www.neurosigma.com/
Neurosigma's LinkedIn profile is https://www.linkedin.com/company/neurosigmainc
Neurosigma has
9 employees.
View email and phone details for 9
employees at Neurosigma.
Neurosigma's industry is
Medical Equipment Manufacturing
Neurosigma's top competitors are
Neuropace,
Graymatters Health,
Brainsway,
Aneuvo,
Lunosa,
Revision Implant,
Neuronetics, Inc.,
Neurolief,
Synapse Biomedical,
Welfie.
Neurosigma's categories are Medical Equipment Manufacturing
